• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    More On VRX.TO

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Valeant Pharmaceuticals International, Inc. (VRX.TO)

    -Toronto
    256.67 Up 9.24(3.73%) 3:59PM EDT
    Add to Portfolio
    Prev Close:247.43
    Open:250.86
    Bid:256.67
    Ask:256.75
    1y Target Est:N/A
    Beta:N/A
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:250.75 - 257.10
    52wk Range:116.01 - 263.91
    Volume:1,144,381
    Avg Vol (3m):414,117
    Market Cap:86.29B
    P/E (ttm):96.13
    EPS (ttm):2.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in CAD.

    Key Statistics

    Forward P/E (1 yr):20.35
    P/S (ttm):10.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :10.62
    Quarterly EPS Est (Mar-15) :2.27
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):1.13

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback